Royalty Pharma plc

RPRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2020

Total Assets: $16.02B

Liabilities Breakdown FY2020

Total Liabilities: $6.12B